Ionocyte-Specific Regulation of Cystic Fibrosis Transmembrane Conductance Regulator

被引:10
|
作者
Sato, Yukiko [1 ,2 ]
Kim, Dusik [1 ,2 ]
Turner, Mark J. [1 ,2 ]
Luo, Yishan [1 ,2 ]
Zaidi, Syeda Sadaf Zehra [1 ,2 ]
Thomas, David Y. [2 ,3 ]
Hanrahan, John W. [1 ,2 ,4 ]
机构
[1] McGill Univ, Dept Physiol, Montreal, PQ, Canada
[2] McGill Univ, Cyst Fibrosis Translat Res Ctr, Montreal, PQ, Canada
[3] McGill Univ, Dept Biochem, Montreal, PQ, Canada
[4] McGill Univ, Res Inst, Hlth Ctr, Montreal, PQ, Canada
关键词
cystic fibrosis; FOXI1; phosphodiesterase; 1C; adenylyl cyclase 5; ITI-214; CYCLIC-NUCLEOTIDE PHOSPHODIESTERASES; AIRWAY SURFACE LIQUID; CELLS; CFTR; CAMP; PH; MODULATION; SECRETION; MEMBRANE; CHANNELS;
D O I
10.1165/rcmb.2022-0241OC
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
CFTR (cystic fibrosis transmembrane conductance regulator) is a tightly regulated anion channel that mediates chloride and bicarbonate conductance in many epithelia and in other tissues, but whether its regulation varies depending on the cell type has not been investigated. Epithelial CFTR expression is highest in rare cells called ionocytes. We studied CFTR regulation in control and ionocyte-enriched cultures by transducing bronchial basal cells with adenoviruses that encode only eGFP or FOXI1 (forkhead box I1) + eGFP as separate polypeptides. FOXI1 dramatically increased the number of transcripts for ionocyte markers ASCL3 (Achaete-Scute Family BHLH Transcription Factor 3), BSND, ATP6V1G3, ATP6V0D2, KCNMA1, and CFTR without altering those for secretory (SCGB1A1), basal (KRT5, KRT6, TP63), goblet (MUC5AC), or ciliated (FOXJ1) cells. The number of cells displaying strong FOXI1 expression was increased 7-fold, and there was no evidence for a broad increase in background immunofluorescence. Total CFTR mRNA and protein levels increased 10-fold and 2.5-fold, respectively. Ionocyte-enriched cultures displayed elevated basal current, increased adenylyl cyclase 5 expression, and tonic suppression of CFTR activity by the phosphodiesterase PDE1C, which has not been shown previously to regulate CFTR activity. The results indicate that CFTR regulation depends on cell type and identifies PDE1C as a potential target for therapeutics that aim to increase CFTR function specifically in ionocytes.
引用
收藏
页码:281 / 294
页数:14
相关论文
共 50 条
  • [31] PHOSPHORYLATION OF THE CYSTIC-FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR
    PICCIOTTO, MR
    COHN, JA
    BERTUZZI, G
    GREENGARD, P
    NAIRN, AC
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1992, 267 (18) : 12742 - 12752
  • [32] Cystic fibrosis transmembrane conductance regulator and adenosine triphosphate
    Abraham, EH
    Okunieff, P
    Scala, S
    Vos, P
    Oosterveld, MJS
    Chen, AY
    Shrivastav, B
    Guidotti, G
    SCIENCE, 1997, 275 (5304) : 1324 - 1325
  • [33] Pharmacology of CFTR (cystic fibrosis transmembrane conductance regulator)
    Cuthbert, A. W.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2004, 18 : 22 - 22
  • [34] A transistor model for the cystic fibrosis transmembrane conductance regulator
    Hunt, William D.
    Mccarty, Nael A.
    Marin, Eduardo Martinez
    Westafer, Ryan S.
    Yamin, Phillip R.
    Cui, Guiying
    Eckford, Andrew W.
    Denison, Douglas R.
    BIOPHYSICAL REPORTS, 2023, 3 (02):
  • [35] ATPase activity of the cystic fibrosis transmembrane conductance regulator
    Li, CH
    Ramjeesingh, M
    Wang, W
    Garami, E
    Hewryk, M
    Lee, D
    Rommens, JM
    Galley, K
    Bear, CE
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (45) : 28463 - 28468
  • [36] Misfolding of the cystic fibrosis transmembrane conductance regulator and disease
    Cheung, Joanne C.
    Deber, Charles M.
    BIOCHEMISTRY, 2008, 47 (06) : 1465 - 1473
  • [37] Targeted Activation of Cystic Fibrosis Transmembrane Conductance Regulator
    Villamizar, Olga
    Waters, Shafagh A.
    Scott, Tristan
    Saayman, Sheena
    Grepo, Nicole
    Urak, Ryan
    Davis, Alicia
    Jaffe, Adam
    Morris, Kevin V.
    MOLECULAR THERAPY, 2019, 27 (10) : 1737 - 1748
  • [38] CYSTIC-FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR (CFTR)
    HIGGINS, CF
    BRITISH MEDICAL BULLETIN, 1992, 48 (04) : 754 - 765
  • [39] Tritherapy with cystic fibrosis transmembrane conductance regulator protein modulators in cystic fibrosis
    Colodro, Oscar Fielbaum
    Grell, Alberto Vidal
    Yarur, Alejandra Mendez
    Clerc, Camila Sobarzo
    ANDES PEDIATRICA, 2022, 93 (06): : 898 - 905
  • [40] Cystic fibrosis as a disease of misprocessing of the cystic fibrosis transmembrane conductance regulator glycoprotein
    Riordan, JR
    AMERICAN JOURNAL OF HUMAN GENETICS, 1999, 64 (06) : 1499 - 1504